JPH07140141A - Organismic component purifying apparatus and gene inspection apparatus - Google Patents

Organismic component purifying apparatus and gene inspection apparatus

Info

Publication number
JPH07140141A
JPH07140141A JP28855593A JP28855593A JPH07140141A JP H07140141 A JPH07140141 A JP H07140141A JP 28855593 A JP28855593 A JP 28855593A JP 28855593 A JP28855593 A JP 28855593A JP H07140141 A JPH07140141 A JP H07140141A
Authority
JP
Japan
Prior art keywords
gene
electric field
separating
cell
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP28855593A
Other languages
Japanese (ja)
Inventor
Hideichiro Yamaguchi
秀一郎 山口
Yukihiko Matsuura
行彦 松浦
Hiroshi Shimane
博 島根
Katsuaki Kikuchi
克明 菊地
Sadayuki Sakuma
貞行 佐久間
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp filed Critical Terumo Corp
Priority to JP28855593A priority Critical patent/JPH07140141A/en
Publication of JPH07140141A publication Critical patent/JPH07140141A/en
Pending legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

PURPOSE:To provide a system for extracting, purifying and inspecting a DNA easily and efficiently without requiring any skill in which a DNA is extracted automatically from a cell when a solution containing cells is injected, and objective DNA is separated, demarcated and inspected. CONSTITUTION:After cell components are separated by a first separating means 10, the cell is subjected to cytoclasis by applying a high voltage pulse from a field generating means 20. Genes spring out from the nucleus of cell simultaneously with cytoclasis and subjected to membrane separation by a second separating means 30 before the genes are cut into fragments by further applying high voltage pulse. The fragmental genes are guided by a gene detecting means 40 while being separated by a small quantity at a time through electrophoresis thus measuring the DNA.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、検査試料、特にヒトお
よび動物の細胞から、遺伝子、タンパク質、酵素等の生
体成分、特にゲノムDNAを効率的に抽出・精製する装
置に関する。また、本発明は、検査試料、特にヒトおよ
び動物の細胞からゲノムDNAを効率的に抽出・精製
し、得られたゲノムDNAを同定するのに用いる遺伝子
検査装置に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an apparatus for efficiently extracting and purifying biological components such as genes, proteins and enzymes, particularly genomic DNA, from test samples, particularly human and animal cells. The present invention also relates to a genetic test device used for efficiently extracting and purifying genomic DNA from a test sample, particularly human and animal cells, and identifying the obtained genomic DNA.

【0002】[0002]

【従来の技術】近年、遺伝子操作技術の目覚ましい発展
に伴い、種々の疾患を遺伝子レベルで解析することが可
能になりつつある。例えばフィコル(Ficoll)法のよう
な複雑な方法で抹消血管から採取された血液中の白血球
からゲノムDNAを抽出した後、Dot blot 法、in situ
Hybridization 法、Southern blotting 法等の手法を
用いて解析し、遺伝子疾患等の診断を行うなどである。
2. Description of the Related Art In recent years, it has become possible to analyze various diseases at a gene level with the remarkable development of gene manipulation technology. For example, after extracting genomic DNA from leukocytes in blood collected from peripheral blood vessels by a complicated method such as Ficoll method, Dot blot method, in situ
Analysis is performed using techniques such as the Hybridization method and Southern blotting method to diagnose genetic diseases.

【0003】しかしながら、上記フィコル法は、「ヘパ
リン等の抗凝固剤を添加した血液に等量のリン酸緩衝食
塩液(PBS、pH 7.4)を加えて十分混和し、これを
分離剤を収容したスピッツ管に静かに注入して、希釈し
た血液試料を分離剤の上に重層し、400g30分遠心
した後、白血球を含む中間層を採取してこれを別のスピ
ッツ管に採りPBSを加えて混和し洗浄を行い、これを
今度は160g10分遠心し、さらに、上清を取り除き
PBSを加えて混和し100g10分遠心するという操
作を2回繰り返した後、上清を取り除き必要とする溶媒
に浮遊させ、最後に顕微鏡で数を算定し、白血球の数を
必要数に調整する。」というものであり、操作が非常に
複雑であり、長時間を要し、また操作者の熟練を要する
ものであった。
However, according to the Ficoll method, "an equivalent amount of phosphate buffered saline (PBS, pH 7.4) is added to blood to which an anticoagulant such as heparin has been added, and the mixture is sufficiently mixed to contain a separating agent. Gently inject into a Spitz tube, overlay the diluted blood sample on the separating agent, centrifuge at 400 g for 30 minutes, collect the intermediate layer containing white blood cells, collect this in another Spitz tube, add PBS and mix. After washing, and then centrifuging this for 160 g for 10 minutes, further removing the supernatant, adding PBS and mixing and centrifuging for 100 g for 10 minutes, repeat the procedure twice, then remove the supernatant and suspend it in the required solvent. Finally, count the number with a microscope and adjust the number of white blood cells to the required number. "It is very complicated to operate, requires a long time, and requires skill of the operator. It was

【0004】また、Dot blot 法およびin situ Hybridi
zation法は、測定操作が簡単で、操作時間が比較的短い
特長があるが、検出感度が低い問題がある。 Southern
blotting 法は、検出感度が高いが、操作が煩雑で長時
間かかる問題があり、十分な感度を得るためにPCR
法、LCR法により被検査部位のDNAを10万〜10
0万倍に増幅することがなされている。PCR法は極め
て感度が高いが、コンタミネーション及び操作条件が複
雑である問題がある。
In addition, Dot blot method and in situ Hybridi
The zation method has a feature that the measurement operation is easy and the operation time is relatively short, but it has a problem that the detection sensitivity is low. Southern
Although the blotting method has high detection sensitivity, it has a problem that the operation is complicated and takes a long time, and PCR is necessary to obtain sufficient sensitivity.
DNA of the site to be inspected by
It is supposed to be amplified by 100,000 times. The PCR method is extremely sensitive, but has a problem that contamination and operating conditions are complicated.

【0005】[0005]

【発明が解決しようとする課題】しかしながら、このよ
うな従来の遺伝子精製方法では、操作が複雑、煩雑であ
り、時間がかかるという問題があり、遺伝子検査装置に
あっては、多くの装置と複雑な操作、条件を必要とする
ため、コンタミネーションや読み取りミスが発生する問
題もあった。
However, in such a conventional gene purification method, there is a problem that the operation is complicated, complicated, and time-consuming, and the gene testing device is complicated with many devices. Since it requires various operations and conditions, there is a problem that contamination and reading errors occur.

【0006】本発明は上記の事情に鑑みてなされたもの
で、操作が簡単で、熟練を要せず、かつ効率のよい生体
成分、特に遺伝子の抽出・精製・検査のための装置を提
供することを目的とし、細胞を含む溶液を注入すると自
動的に細胞からDNAを取り出し、目的のDNAを分離
分画してDNA検査を行うシステムを提供することを目
的とする。
The present invention has been made in view of the above circumstances, and provides an apparatus for extracting / purifying / inspecting biological components, particularly genes, which is easy to operate, requires no skill, and is efficient. Therefore, it is an object of the present invention to provide a system for automatically taking out DNA from a cell when a solution containing cells is injected, separating and fractionating the target DNA, and performing a DNA test.

【0007】[0007]

【課題を解決するための手段】本発明の解決すべき課題
は、検査試料から細胞成分を分離する第1分離手段と、
得られた細胞成分中の細胞を高電場で破砕し、前記細胞
から生体成分を抽出するための電場発生手段と、抽出さ
れた生体成分を前記細胞から分離するための第2分離手
段とを有し、前記電場発生手段は抽出された生体成分が
前記第2分離手段を通過するように導くことを特徴とす
る生体成分精製装置によって達成される。 前記生体成
分精製装置の精製する生体成分としては、遺伝子(特に
ゲノムDNA)、タンパク質、酵素等が適用できる。
The problem to be solved by the present invention is to provide a first separating means for separating cell components from a test sample,
There is provided an electric field generating means for crushing cells in the obtained cell components under a high electric field to extract biological components from the cells, and a second separating means for separating the extracted biological components from the cells. However, the electric field generating means is achieved by a biological component refining device, which guides the extracted biological component so as to pass through the second separating means. As the biological component to be purified by the biological component purification device, genes (particularly genomic DNA), proteins, enzymes and the like can be applied.

【0008】また、本発明の解決すべき課題は、検査試
料から細胞成分を分離する第1分離手段と、得られた細
胞成分中の有核細胞を高電場で破砕し、前記有核細胞か
ら遺伝子を抽出するための電場発生手段と、抽出された
遺伝子を前記有核細胞から分離するための第2分離手段
と、切断された遺伝子を測定する遺伝子検出手段を有
し、前記電場発生手段の発生する電場によって抽出され
た遺伝子を小断片に切断することを特徴とする遺伝子検
査装置によっても達成される。
Another problem to be solved by the present invention is that the first separating means for separating cell components from a test sample and the nucleated cells in the obtained cell components are crushed in a high electric field to remove the nucleated cells from the nucleated cells. The electric field generating means for extracting a gene, the second separating means for separating the extracted gene from the nucleated cell, and the gene detecting means for measuring the cleaved gene are included. It can also be achieved by a gene testing device characterized in that a gene extracted by an electric field generated is cut into small fragments.

【0009】また、本発明の解決すべき課題は、検査試
料から細胞成分を分離する第1分離手段と、得られた細
胞成分中の有核細胞を高電場で破砕し、前記有核細胞か
ら遺伝子を抽出するための電場発生手段と、抽出された
遺伝子を前記有核細胞から分離するための第2分離手段
と、抽出された遺伝子を小断片に切断する切断手段と、
切断された遺伝子を測定する遺伝子検出手段を有し、前
記電場発生手段は抽出された遺伝子が前記第2分離手段
を通過するように導くことを特徴とする遺伝子検査装置
によっても達成される。
Further, the problem to be solved by the present invention is that the first separating means for separating cell components from the test sample and the nucleated cells in the obtained cell components are crushed in a high electric field to remove the nucleated cells from the nucleated cells. An electric field generating means for extracting the gene, a second separating means for separating the extracted gene from the nucleated cell, and a cutting means for cutting the extracted gene into small fragments,
The present invention can also be achieved by a gene testing device, which has a gene detecting means for measuring a cleaved gene, and the electric field generating means guides the extracted gene to pass through the second separating means.

【0010】上記第1分離手段は、中空糸膜等の透析膜
を用いた透析を行うか、または細胞吸着性の膜を用いて
細胞成分のみを分画させた後、電解質をほとんど含まな
い溶液にて細胞成分のみを分離することが好ましい。
The first separating means performs dialysis using a dialysis membrane such as a hollow fiber membrane or fractionates only cell components using a cell-adsorptive membrane and then a solution containing almost no electrolyte. It is preferable to separate only the cell components by.

【0011】また、上記電場発生手段は、高電圧パルス
を発生する2つの電極からなり、両極は上記第2分離手
段を挟むように設置されることが好ましく、前記第2分
離手段は前記第1分離手段の膜よりも孔径の大きい中空
糸からなり、前記電場発生手段の1極が該第2分離手段
の中空糸の中に設置され、多極は該第2分離手段の中空
糸の外に設置されるものとしても良く、2つの電極が電
気刺激によって孔が開く、電気刺激応答性膜を挟んで設
置されても良い。
It is preferable that the electric field generating means is composed of two electrodes for generating a high voltage pulse, and both electrodes are disposed so as to sandwich the second separating means, and the second separating means is the first separating means. A hollow fiber having a pore diameter larger than that of the membrane of the separating means, one pole of the electric field generating means is installed in the hollow fiber of the second separating means, and the multipole is outside the hollow fiber of the second separating means. The electrodes may be installed, or the two electrodes may be installed with an electrostimulation-responsive membrane sandwiched therebetween, the pores being opened by electrostimulation.

【0012】上記切断手段は、前記電場発生手段が高電
圧パルスを印加することによって兼用することが好まし
いが、制限酵素を投入することによって遺伝子を切断し
ても良い。
The above-mentioned cutting means is preferably also used by the electric field generating means by applying a high voltage pulse, but the gene may be cut by introducing a restriction enzyme.

【0013】上記遺伝子検出手段としては放射線標識や
酵素、蛍光色素で標識したプローブとハイブリダイズさ
せて、電気泳動法を用いて分離検査する方法を用いるこ
とができるが、水素振動子マイクロバランス検出装置を
用いることが最も好ましい。
As the above-mentioned gene detecting means, a method of hybridizing with a probe labeled with a radiolabel, an enzyme or a fluorescent dye and performing a separation test by using an electrophoretic method can be used. Is most preferably used.

【0014】また、切断された遺伝子を前記遺伝子検出
手段まで導く搬送手段としては、2枚のガラス板の間に
設けた溝などの微小流路やキャピラリー内を、前記微小
流路またはキャピラリーの遺伝子流入口から前記遺伝子
検出手段にかけて電圧発生装置を設け、該電圧発生装置
の発生するパルス電圧により遺伝子を電気泳動させ、他
の物質と分離しながら搬送することが好ましい。このと
き、前記微小流路またはキャピラリーの中には遺伝子が
分画しやすいようにゲルを満たしていることが好まし
い。
Further, as a conveying means for guiding the cleaved gene to the gene detecting means, the inside of the microchannel such as a groove provided between two glass plates or the inside of the capillary is provided with the gene inlet of the microchannel or the capillary. It is preferable that a voltage generator is provided from the above to the gene detection means, the gene is electrophoresed by the pulse voltage generated by the voltage generator, and the gene is transferred while being separated from other substances. At this time, it is preferable that the microchannel or the capillary is filled with a gel so that the gene can be easily fractionated.

【0015】[0015]

【作用】本発明は、上記の構成により、前記第1分離手
段によって白血球、リンパ球等の有核細胞を含む細胞成
分を分離した後、前記電場発生手段により高電圧パルス
を印加して細胞を破壊する。このとき電場の大きさ及び
電場をかける時間を特定のものとすることによって、細
胞破壊と同時に遺伝子を細胞核外にまで飛び出させ、飛
び出した遺伝子を前記第2分離手段にて膜分離したの
ち、さらに高電圧パルスを印加して遺伝子を小断片に切
断する。小断片遺伝子は、電気泳動により少量づつ分離
しながら遺伝子検出手段に導かれて、DNA測定がおこ
なわれる。遺伝子の切断は制限酵素を用いて切断しても
よい。
According to the present invention, according to the above-mentioned constitution, after the cell components containing nucleated cells such as white blood cells and lymphocytes are separated by the first separating means, cells are applied by applying a high voltage pulse by the electric field generating means. Destroy. At this time, by making the magnitude of the electric field and the time for which the electric field is applied to be specific, the gene is ejected to the outside of the cell nucleus at the same time as the cell destruction, and the ejected gene is membrane-separated by the second separating means, and then, A high voltage pulse is applied to cut the gene into small pieces. The small fragment gene is introduced into the gene detecting means while being separated into small amounts by electrophoresis, and the DNA is measured. The gene may be cleaved using a restriction enzyme.

【0016】[0016]

【実施例】以下、本発明の実施例を図面を参照にして具
体的に説明する。
Embodiments of the present invention will be specifically described below with reference to the drawings.

【0017】(実施例1)図1は、本発明の1実施例に
よる生体成分精製装置を含む遺伝子検査装置の構成を示
したものである。図1において、10は第1分離手段、
11は中空糸膜、12は該中空糸膜11に透析液を投入
するための透析液流入口、13は透析液流出口、20は
電場発生手段を示している。21は該電場発生手段の負
電極であり、後述する第2分離手段30の中空糸膜31
内に設置される。22は正電極であり、前記中空糸膜3
1の外に設置される。30は第2分離手段であり、前記
第1分離手段10の中空糸膜11よりも孔径の大きい中
空糸膜31と、遺伝子を収集觜、pH調整するための遺
伝子緩衝液を投入する遺伝子緩衝液流入口32とからな
る。以上に示した各構成要素によって、本発明の生体成
分精製装置は構成されている。また、40は遺伝子検出
手段、41はDNA検出センサ、41は共振周波数測定
手段、50は精製された遺伝子の通過する微小流路、5
1は前記微小流路内で遺伝子を導く電圧発生装置、52
は切断された遺伝子を前記微小流路51へ導入するため
の導入手段を示しており、前記遺伝子精製装置とこれら
を連続的に組むことにより、検査試料から遺伝子を精製
し、該遺伝子を測定するまでの一連の作業を連続的に行
うことのできる遺伝子検査装置となる。
(Embodiment 1) FIG. 1 shows the configuration of a genetic testing apparatus including a biological component purifying apparatus according to an embodiment of the present invention. In FIG. 1, 10 is a first separating means,
Reference numeral 11 is a hollow fiber membrane, 12 is a dialysate inlet for introducing a dialysate into the hollow fiber 11, 13 is a dialysate outlet, and 20 is an electric field generating means. Reference numeral 21 denotes a negative electrode of the electric field generating means, which is a hollow fiber membrane 31 of the second separating means 30 described later.
It is installed inside. 22 is a positive electrode, which is the hollow fiber membrane 3
It is installed outside 1. Reference numeral 30 denotes a second separating means, which is a hollow fiber membrane 31 having a pore diameter larger than that of the hollow fiber membrane 11 of the first separating means 10, a gene buffer solution for collecting a gene, and a gene buffer solution for adjusting pH. And an inflow port 32. The biocomponent purification device of the present invention is configured by the above-described components. Further, 40 is a gene detecting means, 41 is a DNA detecting sensor, 41 is a resonance frequency measuring means, 50 is a microchannel through which a purified gene passes, 5
1 is a voltage generator for guiding genes in the microchannel, 52
Indicates an introducing means for introducing the cleaved gene into the microchannel 51. By continuously assembling these with the gene purification device, the gene is purified from the test sample and the gene is measured. It becomes a genetic testing device that can continuously perform a series of operations up to.

【0018】以上のように構成された遺伝子検査装置の
動作を、図1を用いて説明する。血液などの有核細胞を
含む検査試料101を約1ml、第1分離手段10にお
ける中空糸膜11の中に注入し、透析液流入口12より
流入した透析液により、精製の妨げとなる血液中の電解
質および蛋白質等を分離する。ここで、中空糸膜11
は、平均孔径0.1〜1μm、直径0.1〜2mmの単
一の中空糸膜を用いたが、平均孔径0.1〜1μm、直
径0.1〜2mmの中空糸膜を1〜1万本束ねたもので
も良く、多段に積まれた平膜でも良い。このようにして
電解質をほとんど含まなくなった細胞成分102を含む
溶液が、平均孔径1〜10μmと前記第1分離手段10
における中空糸膜11より孔径が大きく、直径0.1〜
2mmの単一の中空糸膜31によって構成される第2分
離手段30内に輸送される。輸送された細胞成分102
に対して、電場発生装置20の負電極21および正電極
22が、前記中空糸膜31の孔33を通して中空糸膜3
1の内外に高電圧パルスを印加すると、孔に電界が集中
するため、比較的小さな電圧で有核細胞を破砕すること
ができる。前記負電極21としては、直径25μm〜1
mm程度の円柱状白金電極が好ましく、正電極22は前
記中空糸膜を取り囲む様に筒状の白金電極とすることが
好ましい。また、本第1実施例においては中空糸膜を用
いたために電極の形状は上述のようなものを採用した
が、後述の第2実施例に示すような平膜を用いる場合、
正電極、負電極ともに板状電極を用いることもできる。
電場発生手段20によって発生させる高電圧パルスは、
電場の大きさと印加時間を好適なものとすることによ
り、細胞破壊と同時に遺伝子としてDNA103を細胞
膜の外に、さらに孔の外まで飛び出させることができ
る。好適な電場の大きさと印加時間は、電場の大きさが
100〜1000V程度、印加時間が10μ秒〜1ミリ
秒である。1000V以上の電圧や1ミリ秒以上の長時
間では、温度が上昇し、遺伝子を含む細胞成分に悪影響
を生じ、正確な遺伝子測定が行えない虞れがあり、10
0V以下の電圧や10μ秒以下の短い電圧では有核細胞
の破砕が起こらず、DNA103を抽出できない虞れが
ある。さらに、中空糸膜31の外に遺伝子抽出液とし
て、pH6〜8程度のトリス塩酸バッファからなる緩衝
液を遺伝子緩衝液流入口32から注入することによっ
て、前記緩衝液の圧力で、飛び出したDNA103を還
流させ、遺伝子検出手段40の方向へ集める。前記緩衝
液は、プロティナーゼK等の除蛋白剤を含むEDTA緩
衝液である事が好ましい。正電極22の付近ではさらに
高電圧パルスが印加されるため、DNA103は小断片
に切断される。切断が不十分な場合には、前記遺伝子抽
出液流入口32から制限酵素を注入することによって、
補うこともできるし、前述の細胞破砕とDNA103の
抽出を重視して電場の大きさと印加時間を設定すること
が好ましい場合には、制限酵素のみで切断されるよう調
整しても良い。小断片DNAは導入手段51の発生する
陰圧によって、2枚のガラス板に間に形成された微小流
路50に注入されて、微小流路50の両端に印加される
電圧発生装置51に電圧により、微小流路50内のゲル
中を、電気泳動により分離しながら、水晶振動子による
遺伝子検出手段40に導かれて、DNA測定として共振
周波数の変化測定がおこなわれる。
The operation of the gene testing apparatus constructed as above will be described with reference to FIG. About 1 ml of the test sample 101 containing nucleated cells such as blood is injected into the hollow fiber membrane 11 in the first separating means 10, and the dialysate flowing from the dialysate inlet 12 prevents the purification in blood. Separation of electrolytes and proteins. Here, the hollow fiber membrane 11
Used a single hollow fiber membrane having an average pore diameter of 0.1 to 1 μm and a diameter of 0.1 to 2 mm. It may be a bundle of many, or flat membranes stacked in multiple stages. The solution containing the cell component 102 containing almost no electrolyte in this way has an average pore diameter of 1 to 10 μm and the first separating means 10 described above.
Has a larger pore diameter than the hollow fiber membrane 11 of
It is transported into the second separating means 30 constituted by a single hollow fiber membrane 31 of 2 mm. Cell component 102 transported
On the other hand, the negative electrode 21 and the positive electrode 22 of the electric field generator 20 pass through the holes 33 of the hollow fiber membrane 31 and the hollow fiber membrane 3
When a high voltage pulse is applied to the inside and outside of No. 1, the electric field is concentrated in the pores, so that the nucleated cells can be disrupted with a relatively small voltage. The negative electrode 21 has a diameter of 25 μm to 1
A cylindrical platinum electrode of about mm is preferable, and the positive electrode 22 is preferably a cylindrical platinum electrode so as to surround the hollow fiber membrane. Further, in the first embodiment, since the hollow fiber membrane is used, the shape of the electrode is as described above. However, when a flat membrane as shown in a second embodiment described later is used,
A plate electrode can be used for both the positive electrode and the negative electrode.
The high voltage pulse generated by the electric field generating means 20 is
By optimizing the magnitude and application time of the electric field, it is possible to cause the DNA 103 to be ejected as a gene to the outside of the cell membrane and further to the outside of the pores at the same time as cell destruction. As for the suitable magnitude of the electric field and the application time, the magnitude of the electric field is about 100 to 1000 V, and the application time is 10 μsec to 1 ms. At a voltage of 1000 V or higher or for a long time of 1 millisecond or longer, the temperature rises, which adversely affects cellular components including genes, and there is a possibility that accurate gene measurement cannot be performed.
At a voltage of 0 V or less or a short voltage of 10 μsec or less, crushing of nucleated cells does not occur, and DNA 103 may not be extracted. Furthermore, by injecting a buffer consisting of Tris-hydrochloric acid buffer having a pH of about 6 to 8 from the gene buffer solution inlet port 32 as a gene extract solution outside the hollow fiber membrane 31, the DNA 103 jumped out by the pressure of the buffer solution is removed. It is refluxed and collected in the direction of the gene detecting means 40. The buffer solution is preferably an EDTA buffer solution containing a deproteinizing agent such as proteinase K. Since a higher voltage pulse is applied near the positive electrode 22, the DNA 103 is cut into small pieces. When the cleavage is insufficient, by injecting a restriction enzyme from the gene extract inlet 32,
If it is preferable to set the magnitude of the electric field and the application time with emphasis on the above-mentioned cell disruption and extraction of the DNA 103, the restriction may be adjusted so that only the restriction enzyme is used for cleavage. The small fragment DNA is injected into the minute channel 50 formed between the two glass plates by the negative pressure generated by the introducing means 51, and a voltage is applied to the voltage generator 51 applied to both ends of the minute channel 50. Thus, the gel in the microchannel 50 is guided to the gene detecting means 40 by the crystal oscillator while separating the gel by electrophoresis, and the change of the resonance frequency is measured as the DNA measurement.

【0019】(実施例2)図2は、本発明の第2実施例
における生体成分精製装置を含む遺伝子検査装置の構成
を示したものである。図2において、10は第1分離手
段、13は細胞吸着性膜、14は該細胞吸着性膜13の
上流に洗浄溶液を投入するための溶液流入口、20は電
場発生手段、21は該電場発生手段の負電極であり、後
述する第2分離手段30の電気刺激応答性膜34の上流
に設置される。22は正電極であり、前記電気刺激応答
性膜34の下流に設置される。30は第2分離手段であ
り、前記電場発生手段20の発生する電場の刺激によっ
て孔が開孔する電気刺激応答性膜34と、遺伝子を収集
し、pH調整するための遺伝子緩衝液を投入する遺伝子
緩衝液流入口32とからなる。以上に示した各構成要素
によって、本発明の遺伝子精製装置は構成されている。
また、40は遺伝子検出手段、50は精製された遺伝子
の通過する微小流路、51は前記微小流路内で遺伝子を
導く電圧発生装置を示しており、前記遺伝子精製装置と
これらを連続的に組むことにより、検査試料から遺伝子
を精製し、該遺伝子を測定するまでの一連の作業を連続
的に行うことのできる遺伝子検査装置となる。
(Embodiment 2) FIG. 2 shows the construction of a gene testing apparatus including a biological component purifying apparatus according to a second embodiment of the present invention. In FIG. 2, 10 is a first separating means, 13 is a cell adsorbing membrane, 14 is a solution inlet for introducing a washing solution upstream of the cell adsorbing membrane 13, 20 is an electric field generating means, and 21 is the electric field. It is a negative electrode of the generating means, and is installed upstream of the electrical stimulus responsive film 34 of the second separating means 30 described later. Reference numeral 22 is a positive electrode, which is installed downstream of the electrical stimulus responsive membrane 34. Reference numeral 30 denotes a second separating means, and an electric stimulus responsive membrane 34 having pores opened by stimulation of the electric field generated by the electric field generating means 20 and a gene buffer solution for collecting genes and adjusting pH are added. It comprises a gene buffer inlet 32. The gene purification device of the present invention is constituted by the above-described components.
Further, 40 is a gene detecting means, 50 is a microchannel through which a purified gene passes, and 51 is a voltage generator that guides the gene in the microchannel. By assembling, the gene testing device can purify a gene from a test sample and continuously perform a series of operations from measuring the gene.

【0020】以上のように構成された遺伝子検査装置の
動作は、基本的には図1に示した本発明の第1実施例と
同様であるため、同一箇所には同一番号を付与して説明
を省略し、異なる点のみ説明する。本第2実施例の遺伝
子検査装置の特徴は、細胞吸着性の膜13を用いること
によって、血液などの有核細胞を含む検査試料101か
ら有核細胞を選択的に固着させて容易に分離することが
できる点である。前記細胞吸着性膜13によって有核細
胞を吸着させると、次に電解質をほとんど含まない洗浄
溶液を溶液流入口14から注入して洗浄することによ
り、有核細胞のみが第2分離手段30へ流送される。第
2分離手段30では、電場発生手段20によって高電圧
パルスを印加して、有核細胞を破砕する。このときも高
電圧パルスも実施例1と同様、細胞破壊と同時にDNA
103を細胞膜の外にまで飛び出させるようにするよう
電場の大きさと印加時間を好適なものに設定する。高電
圧パルスの発生に伴い、電気刺激応答性膜34の孔が開
き、飛び出したDNA103が分離される。電気刺激応
答性膜34は、電場が無いときは孔が塞がった状態にあ
るため、DNA103以外の不要な物質を通過させる可
能性が低くなる。その後、さらにDNA103が小断片
に切断され、微小流路50内を電気泳動により分離しな
がら、遺伝子検出手段40に導かれ、DNA測定が行わ
れる過程は、実施例1と同様である。
Since the operation of the gene testing apparatus constructed as described above is basically the same as that of the first embodiment of the present invention shown in FIG. 1, the same parts are designated by the same reference numerals for description. Will be omitted and only different points will be described. The feature of the gene testing device of the second embodiment is that by using the cell-adsorptive membrane 13, the nucleated cells are selectively fixed and easily separated from the test sample 101 containing the nucleated cells such as blood. This is a point that can be done. When the nucleated cells are adsorbed by the cell-adsorptive membrane 13, a washing solution containing almost no electrolyte is then injected from the solution inlet 14 to wash the nucleated cells, so that only the nucleated cells flow to the second separating means 30. Will be sent. In the second separating means 30, a high voltage pulse is applied by the electric field generating means 20 to crush the nucleated cells. At this time, the high-voltage pulse was also applied to the DNA at the same time as the cell destruction as in Example 1.
The magnitude of the electric field and the application time are set to be suitable so that 103 can be projected to the outside of the cell membrane. With the generation of the high-voltage pulse, the holes of the electrostimulation-responsive film 34 are opened, and the protruding DNA 103 is separated. Since the pores of the electric stimulus responsive film 34 are closed when there is no electric field, the possibility of passing unnecessary substances other than the DNA 103 is low. After that, the process in which the DNA 103 is further cut into small fragments and introduced into the gene detecting means 40 while separating the inside of the minute channel 50 by electrophoresis and the DNA measurement is performed is the same as in the first embodiment.

【0021】[0021]

【発明の効果】以上の説明から明らかなように、本発明
の遺伝子精製装置および遺伝子検査装置は、システムが
一体化されているので、取扱いが簡単で、コンタミネー
ションや読み取りミスなどが発生し難く、また、システ
ムを小型化することができので検体量が少なくてよい。
更に、操作が簡単であるので、従来法に比較して迅速な
測定が可能であると、同時に多種類検査に用いることが
できる。
As is apparent from the above description, the gene purifying apparatus and the gene testing apparatus of the present invention have an integrated system, so that they are easy to handle, and contamination and reading errors are less likely to occur. In addition, since the system can be downsized, the amount of sample can be small.
Furthermore, since the operation is simple, the quick measurement as compared with the conventional method enables simultaneous use in many kinds of tests.

【0022】また、本発明の分離手段には膜を使うこと
により費用を安く押さえることができ、さらに検出部分
は、再生可能なので、繰り返し使用して検査コストを低
くできる。
Further, the cost can be kept low by using a membrane for the separating means of the present invention, and further, since the detection part can be regenerated, the inspection cost can be reduced by repeatedly using it.

【0023】また、医学的に見ると、本発明によれば、
ヒト遺伝子の解明が加速され、遺伝子レベルで病因診断
や難病治療に貢献し、人類の福祉に役立つことが期待さ
れる。
From a medical point of view, according to the present invention,
It is expected that the elucidation of human genes will be accelerated, contribute to the etiology diagnosis and treatment of intractable diseases at the gene level, and be useful for human welfare.

【0024】また、癌遺伝子や癌抑制遺伝子を効率よく
解明できるので、再発や発症の予防への手法の選択の幅
が広がる。また、HIVウイルス、HCVウイルス等の
感染症を遺伝子レベルで精確にかつ迅速に診断して、初
期の段階で根本治療を実行することができるようになる
効果がある。
Further, since the oncogene and the tumor suppressor gene can be efficiently elucidated, the range of choice of the method for preventing recurrence and onset is broadened. Further, there is an effect that an infectious disease such as HIV virus and HCV virus can be accurately and promptly diagnosed at a gene level and a fundamental treatment can be executed at an early stage.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明の第1実施例における遺伝子精製装置を
含む遺伝子検査装置を説明する図面である。
FIG. 1 is a diagram illustrating a gene testing device including a gene purification device according to a first embodiment of the present invention.

【図2】本発明の第1実施例における遺伝子精製装置を
含む遺伝子検査装置を説明する図面である。
FIG. 2 is a diagram illustrating a gene testing device including the gene purification device according to the first embodiment of the present invention.

【符号の説明】 10 第1分離手段 11,33 中空糸膜 12 透析液流入口 14 溶液流入口 20 電場発生手段 21、22 電極 30 第2分離手段 34 電気刺激応答性膜 40 遺伝子検出手段 50 微小流路[Explanation of Codes] 10 First Separation Means 11, 33 Hollow Fiber Membrane 12 Dialysate Inlet 14 Solution Inlet 20 Electric Field Generating Means 21, 22 Electrode 30 Second Separation Means 34 Electrical Stimuli Responsive Membrane 40 Gene Detecting Means 50 Micro Channel

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 C12Q 1/68 Z 9453−4B G01N 1/28 (72)発明者 菊地 克明 神奈川県足柄上郡中井町井ノ口1500番地 テルモ株式会社内 (72)発明者 佐久間 貞行 神奈川県足柄上郡中井町井ノ口1500番地 テルモ株式会社内─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI Technical display location C12Q 1/68 Z 9453-4B G01N 1/28 (72) Inventor Katsuaki Kikuchi Inoguchi, Nakai-cho, Ashigaragami-gun, Kanagawa Prefecture No. 1500 Terumo Corporation (72) Inventor Sadayuki Sakuma No. 1500 Inoguchi, Nakai-cho, Ashigarakami-gun, Kanagawa Prefecture Terumo Corporation

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 検査試料から細胞成分を分離する第1分
離手段と、得られた細胞成分中の細胞を高電場で破砕
し、前記細胞から精製すべき生体成分を抽出するための
電場発生手段と、抽出された生体成分を前記細胞から分
離するための第2分離手段とを有し、前記電場発生手段
は抽出された生体成分が前記第2分離手段を通過するよ
うに導くことを特徴とする生体成分精製装置。
1. A first separating means for separating cell components from a test sample, and an electric field generating means for crushing cells in the obtained cell components in a high electric field to extract biological components to be purified from the cells. And a second separating means for separating the extracted biological component from the cells, and the electric field generating means guides the extracted biological component to pass through the second separating means. A biological component purifying device.
【請求項2】 検査試料から細胞成分を分離する第1分
離手段と、得られた細胞成分中の有核細胞を高電場で破
砕し、前記有核細胞から遺伝子を抽出するための電場発
生手段と、抽出された遺伝子を前記有核細胞から分離す
るための第2分離手段と、切断された遺伝子を測定する
遺伝子検出手段を有し、前記電場発生手段の発生する電
場によって抽出された遺伝子を小断片に切断することを
特徴とする遺伝子検査装置。
2. A first separating means for separating cell components from a test sample, and an electric field generating means for crushing nucleated cells in the obtained cell components with a high electric field and extracting a gene from the nucleated cells. And a second separating means for separating the extracted gene from the nucleated cell, and a gene detecting means for measuring the cleaved gene, wherein the gene extracted by the electric field generated by the electric field generating means is A genetic testing device characterized by cutting into small pieces.
JP28855593A 1993-11-18 1993-11-18 Organismic component purifying apparatus and gene inspection apparatus Pending JPH07140141A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP28855593A JPH07140141A (en) 1993-11-18 1993-11-18 Organismic component purifying apparatus and gene inspection apparatus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28855593A JPH07140141A (en) 1993-11-18 1993-11-18 Organismic component purifying apparatus and gene inspection apparatus

Publications (1)

Publication Number Publication Date
JPH07140141A true JPH07140141A (en) 1995-06-02

Family

ID=17731768

Family Applications (1)

Application Number Title Priority Date Filing Date
JP28855593A Pending JPH07140141A (en) 1993-11-18 1993-11-18 Organismic component purifying apparatus and gene inspection apparatus

Country Status (1)

Country Link
JP (1) JPH07140141A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100901485B1 (en) * 2007-08-27 2009-06-08 연세대학교 산학협력단 DNA extracting device of livestock products and DNA extracting method using same
KR100946189B1 (en) * 2008-09-17 2010-03-08 연세대학교 산학협력단 Apparatus for extracting DNA of livestock products and method for extracting DNA using same
JP2012523849A (en) * 2009-04-20 2012-10-11 オリジンオイル,インコーポレイテッド Systems, devices and methods for obtaining intracellular products and cell clumps and debris from algae, and derivatives and uses thereof
JP2015031549A (en) * 2013-08-01 2015-02-16 国立大学法人 香川大学 Cell space fractionation device and fine structure blade

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100901485B1 (en) * 2007-08-27 2009-06-08 연세대학교 산학협력단 DNA extracting device of livestock products and DNA extracting method using same
KR100946189B1 (en) * 2008-09-17 2010-03-08 연세대학교 산학협력단 Apparatus for extracting DNA of livestock products and method for extracting DNA using same
JP2012523849A (en) * 2009-04-20 2012-10-11 オリジンオイル,インコーポレイテッド Systems, devices and methods for obtaining intracellular products and cell clumps and debris from algae, and derivatives and uses thereof
JP2015031549A (en) * 2013-08-01 2015-02-16 国立大学法人 香川大学 Cell space fractionation device and fine structure blade

Similar Documents

Publication Publication Date Title
AU2016271428B2 (en) A component of a device, a device, and a method for purifying and testing biomolecules from biological samples
US11292012B2 (en) Apparatus for performing contactless optically-induced dielectrophoresis for separation of circulating tumor cells
EP2764347B1 (en) Devices for detecting a particle in a sample and methods for use thereof
CN205115443U (en) Collection draws, amplifys and detects integrated gene detection device
CN112760209B (en) Cat coronavirus integration nucleic acid detection card box
US20080302662A1 (en) Method And Apparatus Of Concentration And Purification Of Nucleic Acid
JP4234486B2 (en) Apparatus and method for trapping and releasing DNA or charged linear molecules
CN105132571B (en) Dissociated the method for mitochondrial DNA content using droplet type digitlization PCR detection peripheral bloods
Gunasekera et al. Electrophoretic behavior of individual nuclear species as determined by capillary electrophoresis with laser‐induced fluorescence detection
CN1734265A (en) A kind of cell inclusion analytical approach based on micro-fluidic chip
US20200016606A1 (en) Apparatus for performing contactless optically-induced dielectrophoresis for separation of circulating tumor cells
EP1568766B1 (en) Device for pretreating specimen
JPS58198759A (en) Blood glucose meter
EP4624587A1 (en) Rapid antibiotic susceptibility test and identification method
WO2012065075A2 (en) Electrokinetic devices and methods for high conductance and high voltage dielectrophoresis (dep)
US11241699B2 (en) Apparatus for performing contactless optically-induced dielectrophoresis for separation of circulating tumor cells
JP2003159054A (en) Genetic diagnostic device
JP2004093297A (en) Gene diagnosis apparatus and gene diagnosis method
Loots The role of extracellular vesicles in metastasis
CN120988807A (en) Nucleic acid sequence separation equipment, methods and applications based on capillary electrophoresis
CN118112124A (en) A sensitive and easy-to-use label-free single-cell proteomics analysis method
US20230313267A1 (en) Electrophoretic Collection Device and Nucleic Acid Pretreatment Device
JPH0217077B2 (en)
CN120026091A (en) Microfluidic chip and nucleic acid enrichment detection method based on gradient gel electrophoresis
KR100487912B1 (en) System for detecting cerebral apoplexy and lab-on-a chip thereof